macitentan

Italy

Drugs containing this active substance

  • MACITENTAN EG

    It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children under 18 years of age weighing at least 40 kg. It helps to widen the pulmonary arteries, making it easier for the heart to pump blood and relieving symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan -

    ATC: C02KX04

    Manufacturer: EG S.P.A.

  • It is used in adults and children (over 18 years of age and weighing at least 40 kg) for the long-term treatment of pulmonary arterial hypertension. The medicine helps to widen the pulmonary arteries, making it easier for the heart to pump blood and relieving symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan -

    ATC: C02KX04

    Manufacturer: GLENMARK ARZNEIMITTEL GMBH

  • It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children under 18 years of age weighing at least 40 kg. The drug helps to widen the pulmonary arteries, making it easier for the heart to pump blood and lowering the pressure in the pulmonary circulation.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan -

    ATC: C02KX04

    Manufacturer: OLPHA AS

  • It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children under 18 years of age weighing at least 40 kg. The medicine helps to widen the pulmonary arteries, making it easier for the heart to work and lowering blood pressure in the pulmonary circulation.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan -

    ATC: C02KX04

    Manufacturer: SANDOZ S.P.A.

  • It is used for the long-term treatment of pulmonary arterial hypertension in adults and children (over 18 years of age and weighing at least 40 kg) classified as WHO functional class II or III. The drug helps to widen the pulmonary arteries, facilitating blood flow and improving symptoms such as fatigue, dizziness, and shortness of breath.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan -

    ATC: C02KX04

    Manufacturer: FARMOZ - SOCIEDADE TECNICO MEDICINAL, S.A.

  • It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and children under 18 years of age weighing at least 40 kg.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan -

    ATC: C02KX04

    Manufacturer: TEVA ITALIA S.R.L.

  • It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children under 18 years of age weighing at least 40 kg. The drug helps to widen the pulmonary arteries, facilitating the pumping of blood by the heart and improving symptoms such as fatigue, dizziness, and shortness of breath.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan -

    ATC: C02KX04

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • It is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and children aged 2 years and older weighing at least 40 kg.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan -

    ATC: C02KX04

    Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.

  • It is used in adults for the long-term treatment of Class II or Class III pulmonary arterial hypertension (PAH). It helps to dilate the pulmonary arteries, making it easier for the heart to work and reducing blood pressure.

    Form: tablets, film-coated

    Active substance Dosage
    macitentan -
    tadalafil -

    ATC: C02KX54

    Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.